Juvenile Idiopathic Inflammatory Myopathies
The juvenile idiopathic inflammatory myopathies (JIIM) are a group of rare, chronic, autoimmune illnesses that affect muscle and, to a lesser extent, skin. The presence of new-onset weakness and, in juvenile dermatomyositis, typical rahes, should lead to consideration of these diagnoses. Careful evaluation to exclude alternative diagnoses is needed. Investigations include a variety of blood tests, imaging, and possibly muscle biopsy. Validated clinical assessments are available for monitoring. Standard treatment includes corticosteroids and methotrexate and often extends beyond 1 year. Outcomes are generally good, but disease persistence remains problematic. Early involvement of providers with expertise in JIIM is essential.
Source: Pediatric Clinics of North America - Category: Pediatrics Authors: Adam M. Huber Source Type: research
More News: Autoimmune Disease | Corticosteroid Therapy | Dermatology | Dermatomyositis | Methotrexate | Pediatrics | Skin | Skin Biopsy